How much is Waystar Health worth in 2026?

Waystar Health has a current valuation of N/A based on their PE Growth/Expansion round and secondary market data.

How much funding has Waystar Health raised?

Waystar Health has raised N/A in total funding across 1 funding rounds.

Waystar Health

Enterprise Systems (Healthcare)

Waystar Health valuation and funding history | Last updated: September 15, 2020 | 1 funding rounds

Current Valuation

N/A

As of September 15, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

PE Growth/Expansion

$2.1B

Last Funding

Sep 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 15, 2020	PE Growth/Expansion	$2.1B	N/A	-

Valuation Analysis

Current Valuation Metrics

Waystar Health is currently valued at N/A as of September 15, 2020.

Track Waystar Health Valuation Updates

Get notified when Waystar Health raises new funding or valuation changes

Explore More Data

Detailed analysis for Waystar Health

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Waystar Health's valuation history, funding rounds, and growth metrics.

No credit card required

What is Waystar Health Worth in 2026?

Waystar Health is a leading private company in the Enterprise Systems (Healthcare) sector. Track Waystar Health's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Waystar Health Valuation is Determined

Private company valuations like Waystar Health's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.